Effect of pre- and postoperative plasmapheresis on posttransplant recurrence of focal segmental glomerulosclerosis in children

Citation
T. Ohta et al., Effect of pre- and postoperative plasmapheresis on posttransplant recurrence of focal segmental glomerulosclerosis in children, TRANSPLANT, 71(5), 2001, pp. 628-633
Citations number
26
Categorie Soggetti
Medical Research Diagnosis & Treatment
Journal title
TRANSPLANTATION
ISSN journal
00411337 → ACNP
Volume
71
Issue
5
Year of publication
2001
Pages
628 - 633
Database
ISI
SICI code
0041-1337(20010315)71:5<628:EOPAPP>2.0.ZU;2-E
Abstract
Background Posttransplant recurrence is frequent in patients who received r enal transplantation for focal segmental glomerulosclerosis (FSGS), The rec urrence has been ascribed to a circulating permeability factor or factors. We have used plasmapheresis (PP) to treat recurrent FSGS and also studied w hether preoperative PP is effective in preventing recurrence of FSGS, Methods. We retrospectively analyzed 21 allografts of 20 patients with neph rotic syndrome and biopsyproven FSGS, They were divided into two groups dep ending on whether they had prophylactic PP; a prophylactic (n=15) and a non prophylactic group (n=6), PP was performed two to three times prophylactica lly and therapeutically until proteinuria was markedly reduced. In each ses sion, 50-75 ml/kg of the patient's plasma was exchanged with 5-8% albumin, Results. FSGS recurred in 9 of 21 allografts, 4 of 6 in the nonprophylactic group, and 5 of 15 in the prophylactic group. Therapeutic PP was performed in seven of nine recurrent patients without definite adverse effect, with satisfactory results except in one patient. Children lost proteinuria after 6 to > 100 sessions of PP and the number correlated with the pretreatment level of proteinuria, The mean follow-up periods were 62.7 and 41.6 months for the prophylactic and nonprophylactic groups, respectively, At the last follow-up, 66.7% of relapsing and 81.8% of nonrelapsing patients had a func tioning graft. Conclusion, PP appears to be effective for the prevention and treatment of posttransplant recurrence of FSGS, although further consideration of cost/b enefit and risks is required before a conclusive judgement can be made.